Opko Health, Inc.
Opko Health, Inc. is an innovative healthcare company focused on diagnostics, pharmaceuticals, and biologics.
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying Opko Health's stock with a target price of $4.25, indicating potential growth.
Financial Health
Opko Health is generating decent revenue and cash flow, but its profitability is relatively low.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring OPK
Walgreens' Restructuring: A New Healthcare Landscape
Following its $10 billion acquisition by Sycamore Partners, Walgreens is going private and splitting into five separate companies. This major restructuring of a key industry player could create significant opportunities for competitors and specialized healthcare service providers to capture market share.
Published: August 29, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Pipeline Milestones Ahead
Clinical and regulatory milestones can materially affect value, offering upside if successful — though outcomes are uncertain and timing can vary.
Diagnostics Revenue Stream
Diagnostic testing and lab services provide recurring revenue diversity, but volumes can fluctuate with market demand and reimbursement changes.
Capital & Dilution
Small‑cap healthcare firms may need additional funding to advance programmes, which can dilute shareholders; review the balance sheet carefully.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Eli Lilly and Company
Eli Lilly & Co is a global pharmaceutical company that develops, manufactures and markets human prescription drugs.
Johnson & Johnson
Johnson & Johnson is a multinational conglomerate pharmaceutical, medical devices, and consumer packaged goods company.
AbbVie Inc.
Abbvie is a research-based biopharmaceutical company that develops and markets advanced therapies to address complex medical conditions.
